Enliven Therapeutics (ELVN) EPS (Basic) (2019 - 2026)
Enliven Therapeutics (ELVN) reported EPS (Basic) of -$0.44 for Q1 2026, up 29.95% on a YoY basis from -$0.34 in Q1 2025, and up 26.75% sequentially from -$0.61 in Q4 2025.
Enliven Therapeutics (ELVN) EPS (Basic) (2019 - 2026) Analysis & Trends
Enliven Therapeutics (ELVN) has 8 years of EPS (Basic) data on file, last reported at -$0.44 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 29.95% year-over-year to -$0.44; the trailing twelve-month figure through Mar 2026 stood at -$1.87 (up 15.73% YoY), and the FY2025 full-year result was -$2.6, up 29.59% from the prior year.
- EPS (Basic) advanced to -$0.44 in Q1 2026, from -$0.61 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.41 in Q3 2025 to a low of -$4.52 in Q4 2022.
- A 5-year average of -$1.03 and a median of -$0.61 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) slumped 70.27% in 2022 and jumped 65.66% in 2023, its largest moves.
- Tracing ELVN's EPS (Basic) over 5 years: stood at -$4.52 in 2022, then surged by 63.65% to -$1.64 in 2023, then jumped by 65.18% to -$0.57 in 2024, then declined by 6.08% to -$0.61 in 2025, then gained by 26.75% to -$0.44 in 2026.
- Business Quant data shows ELVN's EPS (Basic) at -$0.44 in Q1 2026, -$0.61 in Q4 2025, and -$0.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Enliven Therapeutics | 3.22 Bn | 3.22 Bn | - | -0.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | -0.61 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.56 |
| Mar 31, 2025 | -0.63 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -0.52 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.64 |
| Sep 30, 2023 | -0.60 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.89 |
| Dec 31, 2022 | -4.52 |
| Sep 30, 2022 | -1.70 |
| Jun 30, 2022 | -1.44 |
| Mar 31, 2022 | -1.35 |
| Dec 31, 2021 | -2.66 |
| Sep 30, 2021 | -2.24 |
| Jun 30, 2021 | -3.84 |